Wednesday, August 3, 2016

D-Limonene Market - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2022

D - Limonene Market For Personal Care Products, Air Care Products, Cleaning And Furnishing Care Products, Electrical & Electronic Devices, Food Additives And Others Is Expected To Reach Over US$ 0.45 Bn By 2022
According to a new market report published by Credence Research “D - Limonene Market - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2022,” the d - limonene market is expected to reach over US$ 0.45 Bn by 2022, expanding at a CAGR of more than 4.5% from 2016 to 2022.
Browse the full D - Limonene Market for Personal Care Products, Air Care Products, Cleaning and Furnishing Care Products, Electrical & Electronic Devices, Food Additives and Others Applications- Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2022 report at http://www.credenceresearch.com/report/d-limonene-market
Market Insights
Limonene is a liquid hydrocarbon which is colorless and is classified as a cyclic terpene. The isomer of limonene is d – limonene. It is basically used in chemical synthesis and as a renewable solvent in cleaning products. D – Limonene is also known as a cleaning formulation ingredient that is extracted from oils which are present in orange rinds. The pleasant lemon like aroma of d – limonene makes it a major constituent in several citrus oils. Because of its aroma, d – limonene is used as a fragrance and flavor additive in soaps, perfumes, food, beverages, chewing gums and cleaning products.
Decrease in usage of ozone depleting chemicals and chlorofluorocarbon (CFC) is the major driving factor for growth of global d – limonene market worldwide.  In addition, growing demand for d – limonene as a solvent for replacing toxic materials from the solvent blends is another factor boosting growth of global d – limonene market. Based on applications, the global d – limonene market is segmented into personal care precuts, air care products, cleaning and furnishing care products, electrical and electronic devices, food additives and others.
Among these, personal care products accounted for major share of global d – limonene market in 2015 and are expected to increase in the near future. D – Limonene is used in various personal care products such as soaps, creams, lotions, oils and perfumes among others. Hence, high demand is reported for d – limonene from the personal care products industry. Other applications are also expected to boost high demand for d – limonene as it is used in wide range of cleaning products for various applications. Therefore, d – limonene is anticipated to experience high demand from various end-user industries worldwide in the near future.
Competitive Insights:
Latin America accounted for major share of global d – limonene market as Brazil is the major orange producing country. North America followed Latin America in terms of demand for d – limonene in the market. U.S. dominated the global d - limonene market in terms of demand due to increasing use of d – limonene in end-user industries in the country. High demand for d – limonene from the personal care products industry is driving the growth of global d – limonene market in the region. Asia Pacific accounted as the third largest region for d – limonene worldwide and is anticipated to fuel market demand in the near future. Increasing demand for d – limonene from the chemical industry has boosted market growth in the region. Other regions such as Europe and Middle East & Africa are also projected to fuel demand for d – limonene during the forecast period from 2016 to 2022.
Key Trends:
Manufacture of personal care products
High demand as solvent from the chemical industry
Replace toxic materials in solvents and an alternative to harmful ozone depleting chemicals
Opportunities from increasing research activities for increase in application scope of d - limonene from various end-user industries
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290


Flaxseed Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 - 2022

Flaxseed Market to Reach US$ 3,626.1 Mn by 2022
According to a new market research report published by Credence Research “Flaxseed Market (Food, Feed, Pet Food, Paper & Pulp, Textile and Other (personal care, biofuel, building construction among others)) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 - 2022” the global flaxseed market was valued at US$ 1,500.0 Mn in 2014 and is estimated to expand with a CAGR of 12.2% from 2015 to 2022.
Market Insights:
Rising awareness regarding health benefits associated with the consumption of flax seed products is a major factor contributing towards the market growth. Flax seeds are rich in fiber, lignans, and omega-3 fatty acids that helps in the control of cholesterol and blood sugar. Flaxseed are nutritionally enriched when used in animal and human food. Furthermore, flax products helps in protecting against cancer in human. The global market for flax is growing significantly, owing to its rising demand from the food, animal feed and pet food industries. In the U.S. usage of flax in baked goods has more than doubled over the last few years. Currently flaxseed are getting huge demand from the food industry for use in crackers, breads, energy bars, cereals, and snacks.
The demand for flax for energy, industrial products and fabrics is also increasing significantly due to its renewable nature and will gradually become an important as the technology to utilize flax improves. The utilization of flax in livestock, pet health is also growing. Animals also benefit from flax’s nutritional properties. New technology is being developed to improve the utilization of flax in feed while R&D has improved the amount of omega-3 that can be incorporated into livestock and poultry products. Over the coming years it might be possible to use flax in the production of biodegradable packaging films for food.
Competitive Insights:
The entry of major food companies into flax products would help grow the sector. The promotion of flax would increase which would increase consumer awareness and help drive the demand for flax products for food. Some of the players already present in this market are Archer Daniels Midland Company, Optimum Nutrition, Bioriginal Food & Science Corp., Natural Brand and Sundown among others. 
Key Trends:
Focus on enhancing new applications for flax
Emphasis on development new food products including flax for human and animal food
Geographical expansion through organic as well as inorganic growth
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290


Global Hematopoietic Stem Cells Transplantation Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022

Global Hematopoietic Stem Cells Transplantation Market Is Expected To Reach USD 7,796.1 Mn By 2022
The latest market report published by Credence Research, Inc. “Global Hematopoietic Stem Cells Transplantation Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the hematopoietic stem cells transplantation market was valued at USD 3,741.3 Mn in 2015, and is expected to reach USD 7,796.1 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.
Browse the full report Hematopoietic Stem Cells Transplantation Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/hematopoietic-stem-cells-transplantation-market
Market Insights
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system.
Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.
Market Competition Assessment:
The hematopoietic stem cells transplantation market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Kite Pharma Inc., Thermo Fisher Scientific, PromoCell, CellGenix Technologie Transfer GmbH,   Cesca Therapeutics Inc.,  R&D Systems, Genlantis, Lonza Group Ltd., TiGenix N.V., and ScienCell Research Laboratories.
Key Market Movements:
Rising prevalence of leukemia is expected to assist the hematopoietic stem cells transplantation as the survival rates in leukemia patients has been improved after HSCT.
Future opportunity for HSCT market lies in regenerative Stromal Cell Therapy because it is considered as one of the novel therapies for prevention and treatment of acute graft versus host disease in allogeneic HSCT patients.
In emerging economies growing government support through providing favorable environments for research laboratories in the field of stem cell research
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290


Hyaluronic Acid Products Market - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Global Hyaluronic Acid Market Is Projected To Reach USD 11.15 Billion By 2022
In terms of revenue in 2014, the global market for hyaluronic acid was calculated to be USD 5.50 billion and is projected to reach USD 11.15 billion by 2022, growing at a CAGR of 9.7% from 2015 to 2022.
Hyaluronic acid is witnessing growth on the back of rising demand from cosmetics and medical applications. Moreover, growing incidence of ulcers, osteoarthritis and geriatric population is another major factor attributing towards market growth. However, other cost effective treatment present in the market and allergic reaction associated with it can restraint the market growth. Advancement in technology towards better health services is projected to fuel the market demand for hyaluronic acid.
By product type, in 2014, five injection was the leading product type of hyaluronic acid and accounted for 40% share of the market. High usage is one of the major factor attributing towards the market growth. Single injection is forecasted to be the fastest growing market during the forecast period.
In 2014, dermal fillers was the largest application segment for hyaluronic acid and was calculated to be USD 2.04 billion. Vesicoureteral reflux is the fastest growing application segment of hyaluronic acid. Recent improvements are the factors driving the market growth.
In 2014, North America was the largest market accounted for 37% share of the market pie. This is due to presence of geriatric population and high awareness among them regarding the different procedures. Asia Pacific is projected to be the fastest growing market during the forecast period. The market is projected to grow at a CAGR of 10.1% during the forecast period. Rapidly improving health care industry and rising awareness among the growing population are the factors attributing towards the growth. RoW is another lucrative market due to increasing awareness about the use and affects for hyaluronic acid.
Some of the major players present in this market are Salix Pharmaceuticals, Ferring Pharmaceuticals Inc., Anika Therapeutics Inc., and Allergan Inc among others.
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290


Global Needle Free Diabetes Management Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022

Global Needle Free Diabetes Management Market is Expected to Reach USD 9,797.8 Mn by 2022
The latest market report published by Credence Research, Inc. “Global Needle Free Diabetes Management Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the needle free diabetes management  market was valued at USD 3,225.6 Mn in 2015, and is expected to reach USD 9,797.8 Mn by 2022, expanding at a CAGR of 16.8% from 2016 to 2022.
Browse the full report Needle Free Diabetes Management Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/needle-free-diabetes-management-market
Market Insights:
Diabetes is majorly classified into Type 1 diabetes (due to b-cell destruction, usually leading to absolute insulin deficiency), Type 2 diabetes (due to a progressive loss of insulin secretion on the background of insulin resistance) and gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes).
According to the International Diabetes Federation, in 2015 about 415 million people were observed suffering with diabetes and by 2040 the number is expected to soar to 642 million worldwide. In 2015, North America and Caribbean comprised patient population of 44.3 million, Europe possessed 59.8 million, South East Asia had 78.3 million, Western Pacific had 153.2 million, South & Central America had 29.6 million, and Africa had 14.2 million.
The market segmentation of needle free diabetes management market is carried out on the basis of type of devices and geography. The devices segment is further sub-segmented into treatment devices, diagnostic devices and artificial pancreas. Treatment devices comprise of insulin pens, pumps & patches, inhalers and jet injectors.
Insulin patch & pump was observed as the fastest growing segment in treatment devices segment due to high efficiency, patient convenience, and rising public awareness related to the novel needle-free treatment devices. Insulin pens and jet injectors collectively accounted for the largest market share of around 51% of the overall needle-free diabetes treatment market as they are one of the most initial treatment solutions available in the market, high market penetration achieved till date and high public awareness related with the products.
Geography segmentation comprised regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. North America was observed as the largest and most potential regional market for needle free diabetes management market. North America constitutes regional markets of U.S. and Canada, the rising prevalence of diabetes is the major driver for the growth of North America needle free diabetes management market. The developed healthcare infrastructure, high public awareness related to diabetes management, and rising research and development activities related to diabetes management are the key factors assisting the growth of North America needle free diabetes management market.
Market Competition Assessment:
The needle free diabetes management market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Zogenix, Inc., 3M, Antares Pharma Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, Pharmajet, Inc., Bioject Medical Technologies, Inc., Medtronic, Inc., Johnson & Johnson, Inc., Pancreum LLC, Tandem Diabetes Care, Inc., JDRF, and Akra Dermojet.
Key Market Movements:
Rising prevalence of diabetes worldwide as is claimed as one of the most chronic diseases if not well managed and is expected to reach alarming levels in the coming years
The technology to manage diabetes is developing at significant pace some ground breaking innovations in the field of artificial pancreas are considered to change the needle free diabetes management market
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290


Prebiotics In Animal Feed Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 - 2022

Prebiotics in Animal Feed Market to Reach US$ 494.9 Mn by 2022
According to a new market research report published by Credence Research “Prebiotics In Animal Feed Market (Insulin, Mannan oligosaccharides (MOS), Galacto oligosaccharides (GOS),Fructo Oligosaccharide (FOS) and Other - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 - 2022”the global prebiotics in animal feed market was valued at US$ 220.3Mn in 2014 and is estimated to expandwith a CAGR of 11.2% from 2015 to 2022.
Market Insights
The global market for prebiotics in animal feed is majorly backed by the rise in consumption of meat across the globe. Furthermore, multiple health benefits associated with prebiotics when use in animal feedsuch as better digestion, enhancing animal performance and the immune systemis another factor propelling the demand for prebiotics in animal feed.
During the past decade, due to their therapeutic effects antibiotics have been widely used in livestock diets. Nevertheless, due to concern regarding the usage of antibiotic in animal feed might contribute to an increase of bacterial antibiotic resistance, some countries had restricted the use of some types of antibiotics.
In 2006, European Union (EU) has introduced anoverall ban on the usage of antibiotics as feed additives. Thus prebiotics, have emerged as an alternative to antibiotics in animal feed which can not only reduce enteric diseases in livestock animal but also enhance their productivity. Thus, the ban impose on usage of antibiotics in animal feed by many countrieswill also drive the overall market demand for prebiotics in animal feed.
Stringent government guidelines regarding the approval and usage of prebiotics in animal feed coupled up with greater market visibility and shelf space of probiotics is significantly hampering the market growth. However, increasing awareness regarding the health benefits associated with the usage of prebiotics in animal feed is projected to fuel the market demand in the near future.
Competitive Insights:
The global market is highly fragmented due to presence of various multinational and regional players. Therefore, none accounts for significant share of the market pie. The market is characterized by a moderate level of forward and backward integration. Some of the key players present in this market are Beghin Meiji, FrieslandCampina Domo, Cargill Incorporated, Paramus and Abbott Laboratories.
Key Trends:
Geographical expansion through organic as well as inorganic growth
Focus on enhancing different product/ ingredients type of prebiotics
Rising awareness regarding the benefits associated with prebiotics in animal feed will fuel the market growth
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Ph: 1-800-361-8290